# A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-07-31

Status: ACTIVE_NOT_RECRUITING · Sponsor: Janssen Research & Development, LLC · Condition: Carcinoma, Non-Small-Cell Lung

- Company: Janssen Research & Development, LLC
- Sector: Carcinoma, Non-Small-Cell Lung
- Primary source: https://clinicaltrials.gov/study/NCT05488314

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.